An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics

Lignende værker

• Application of Adaptive Design Methodology in Development of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Statistical Design and Simulations
  af: Skrivanek, Zachary, et al.
  Udgivet: (2012)
• Operational Challenges and Solutions with Implementation of an Adaptive Seamless Phase 2/3 Study
  af: Spencer, Kimberly, et al.
  Udgivet: (2012)
• A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
  af: Gurung, Tara, et al.
  Udgivet: (2015)
• In Vitro and in Vivo Evaluation of Native Glucagon and Glucagon Analog (MAR-D28) during Aging: Lack of Cytotoxicity and Preservation of Hyperglycemic Effect
  af: Ward, W Kenneth, et al.
  Udgivet: (2010)
• Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist
  af: Quadri, Hamza, et al.
  Udgivet: (2021)